1.54
price down icon8.88%   -0.15
after-market Dopo l'orario di chiusura: 1.55 0.01 +0.65%
loading
Precedente Chiudi:
$1.69
Aprire:
$1.67
Volume 24 ore:
5.96M
Relative Volume:
0.67
Capitalizzazione di mercato:
$462.13M
Reddito:
$188.87M
Utile/perdita netta:
$-400.38M
Rapporto P/E:
-1.0267
EPS:
-1.5
Flusso di cassa netto:
$-260.90M
1 W Prestazione:
+10.79%
1M Prestazione:
+28.33%
6M Prestazione:
-8.88%
1 anno Prestazione:
-18.09%
Intervallo 1D:
Value
$1.52
$1.70
Intervallo di 1 settimana:
Value
$1.35
$1.71
Portata 52W:
Value
$0.8511
$2.72

Pacific Biosciences Of California Inc Stock (PACB) Company Profile

Name
Nome
Pacific Biosciences Of California Inc
Name
Telefono
650-521-8000
Name
Indirizzo
1305 O'BRIEN DRIVE, MENLO PARK, CA
Name
Dipendente
575
Name
Cinguettio
@pacbio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
PACB's Discussions on Twitter

Confronta PACB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
PACB
Pacific Biosciences Of California Inc
1.54 486.14M 188.87M -400.38M -260.90M -1.50
Medical Devices icon
ABT
Abbott Laboratories
125.64 218.92B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
106.21 152.62B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
396.66 153.22B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
92.32 117.89B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
75.80 45.12B 5.54B 4.18B 623.10M 7.00

Pacific Biosciences Of California Inc Stock (PACB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-11 Downgrade UBS Buy → Neutral
2024-06-03 Ripresa Jefferies Buy
2024-04-22 Downgrade JP Morgan Overweight → Neutral
2024-04-18 Downgrade Goldman Buy → Neutral
2023-12-14 Iniziato Guggenheim Neutral
2023-12-14 Iniziato Stephens Overweight
2023-12-13 Iniziato Wolfe Research Peer Perform
2023-11-17 Aggiornamento UBS Neutral → Buy
2023-10-31 Aggiornamento Cantor Fitzgerald Neutral → Overweight
2023-09-28 Iniziato Bernstein Outperform
2023-07-05 Ripresa JP Morgan Overweight
2023-06-30 Iniziato Goldman Buy
2023-05-10 Iniziato Barclays Equal Weight
2023-03-31 Aggiornamento TD Cowen Market Perform → Outperform
2023-02-02 Iniziato UBS Neutral
2023-01-20 Downgrade Cantor Fitzgerald Overweight → Neutral
2023-01-05 Iniziato Scotiabank Sector Outperform
2022-01-21 Ripresa Cantor Fitzgerald Overweight
2022-01-06 Ripresa Piper Sandler Neutral
2021-10-15 Ripresa Cowen Market Perform
2021-09-27 Iniziato Canaccord Genuity Buy
2021-02-11 Aggiornamento Piper Sandler Neutral → Overweight
2020-11-03 Downgrade Piper Sandler Overweight → Neutral
2020-10-02 Aggiornamento JP Morgan Neutral → Overweight
2020-09-09 Iniziato Morgan Stanley Equal-Weight
2020-06-02 Ripresa Cantor Fitzgerald Overweight
2020-03-09 Ripresa Cantor Fitzgerald Overweight
2019-10-15 Aggiornamento Piper Jaffray Neutral → Overweight
2019-04-02 Downgrade Stephens Overweight → Equal-Weight
2018-10-19 Iniziato Cowen Outperform
2017-11-03 Downgrade First Analysis Sec Overweight → Equal-Weight
2017-09-28 Downgrade CL King Buy → Neutral
2016-11-03 Reiterato Cantor Fitzgerald Buy
2016-06-27 Iniziato CL King Buy
2016-04-15 Iniziato First Analysis Sec Overweight
2016-02-04 Downgrade Piper Jaffray Overweight → Neutral
2016-01-04 Reiterato Cantor Fitzgerald Buy
2015-10-23 Aggiornamento Piper Jaffray Neutral → Overweight
2015-08-27 Iniziato Cantor Fitzgerald Buy
2015-02-04 Reiterato Maxim Group Buy
2013-09-26 Reiterato Maxim Group Buy
2013-01-14 Reiterato Maxim Group Buy
Mostra tutto

Pacific Biosciences Of California Inc Borsa (PACB) Ultime notizie

pulisher
Jul 24, 2025

What makes Pacific Biosciences of California Inc. stock attractive to long term investorsDynamic profit opportunities - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

PacBio (PACB) Technology Powers Significant Genomic Research in Arab Populations | PACB Stock News - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand - Yahoo.co

Jul 24, 2025
pulisher
Jul 24, 2025

Publication spotlight: How Kinnex long-read RNA sequencing wins out over Illumina for transcript-level quantification - PacBio

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Pacific Biosciences of California Inc. stockExceptional earning trajectories - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Why PacBio (PACB) Stock Is Up Today - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

QIAGEN’s New Sequencing Panels Boosts PacBio Expansion - StocksToTrade

Jul 23, 2025
pulisher
Jul 23, 2025

Pacific Biosciences: The Shift To Razor-Blade Economics Could Be A Game Changer - Seeking Alpha

Jul 23, 2025
pulisher
Jul 23, 2025

PacBio Joins 1000 Genomes Long Read Sequencing Project to Enhance Human Genomics Research - Nasdaq

Jul 23, 2025
pulisher
Jul 23, 2025

Is Pacific Biosciences of California Inc. a good long term investmentPhenomenal wealth increase - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

QIAGEN Expands NGS Portfolio with QIAseq xHYB Long Read Panels - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Pacific Biosciences of California Inc. stock priceRapid capital growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Pacific Biosciences of California Inc. Stock Analysis and ForecastOutstanding capital returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

PacBio (PACB) Collaborates with Qiagen for Enhanced Genomic Insi - GuruFocus

Jul 22, 2025
pulisher
Jul 22, 2025

QIAGEN launches long-read sequencing panels for complex genomic regions By Investing.com - Investing.com Canada

Jul 22, 2025
pulisher
Jul 22, 2025

PACB Stock Rally: Bullish Signs or Temporary Spike? - StocksToTrade

Jul 22, 2025
pulisher
Jul 21, 2025

PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025 - Yahoo Finance

Jul 21, 2025
pulisher
Jul 17, 2025

Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know - Yahoo.co

Jul 17, 2025
pulisher
Jul 17, 2025

How long-read sequencing uncovers hitchhikers of the genomic galaxy in parasitic fungi - PacBio

Jul 17, 2025
pulisher
Jul 16, 2025

Pacific Biosciences Stock Jumps Amid Strategic Acquisitions - StocksToTrade

Jul 16, 2025
pulisher
Jul 16, 2025

Pacific Biosciences Sees Stock Uptick Following Strategic Moves - timothysykes.com

Jul 16, 2025
pulisher
Jul 11, 2025

Chromosome-level genome assembly with telomeric repeats at scaffold ends for Rhabdosargus sarba - Nature

Jul 11, 2025
pulisher
Jul 11, 2025

Here's Why You Should Add PacBio Stock to Your Portfolio Now - MSN

Jul 11, 2025
pulisher
Jul 11, 2025

Further Upside For Pacific Biosciences of California, Inc. (NASDAQ:PACB) Shares Could Introduce Price Risks After 29% Bounce - simplywall.st

Jul 11, 2025
pulisher
Jul 10, 2025

Pacific Biosciences of California (PACB) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance

Jul 10, 2025
pulisher
Jul 09, 2025

Pacific Biosciences (PACB) Upgraded to Strong Buy: Here's What You Should Know - MSN

Jul 09, 2025
pulisher
Jul 04, 2025

PACB Stock Price and Chart — NASDAQ:PACB - TradingView

Jul 04, 2025
pulisher
Jul 03, 2025

Pacific Biosciences Sees Stock Surge After Latest Product Launch - timothysykes.com

Jul 03, 2025
pulisher
Jul 03, 2025

Pacific Biosciences Targets Profitability by 2027 With Record Consumables Revenue - Insider Monkey

Jul 03, 2025
pulisher
Jul 02, 2025

Why PACB’s Stock is Rising? - StocksToTrade

Jul 02, 2025
pulisher
Jul 02, 2025

How the Long Read Sequencing Market Will Evolve by 2032Growth, - openPR.com

Jul 02, 2025
pulisher
Jun 25, 2025

Barclays Adjusts Price Target for PacBio (PACB) Amid Funding Con - GuruFocus

Jun 25, 2025
pulisher
Jun 24, 2025

Third Generation Sequencing Market Set to Witness Significant - openPR.com

Jun 24, 2025
pulisher
Jun 21, 2025

Long Read Sequencing Market Projected to Reach USD 6.98 - GlobeNewswire

Jun 21, 2025
pulisher
Jun 12, 2025

Pacific Biosciences of California (PACB) Outperforms Broader Market: What You Need to Know - Yahoo Finance

Jun 12, 2025
pulisher
Jun 12, 2025

Following a 41% decline over last year, recent gains may please Pacific Biosciences of California, Inc. (NASDAQ:PACB) institutional owners - simplywall.st

Jun 12, 2025
pulisher
Jun 12, 2025

Celebrating Father’s Day with new discoveries of the Y chromosome achieved with HiFi sequencing - PacBio

Jun 12, 2025

Pacific Biosciences Of California Inc Azioni (PACB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$286.58
price down icon 0.03%
medical_devices STE
$227.25
price up icon 0.79%
medical_devices PHG
$25.84
price down icon 0.04%
$86.74
price up icon 0.36%
$76.77
price down icon 0.62%
medical_devices EW
$75.80
price down icon 1.44%
Capitalizzazione:     |  Volume (24 ore):